Maia Biotechnology, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
AMEX
SCHEDULE: MAIA Biotech CEO Boosts Stake to 9.66%
MAIA Biotechnology, Inc.'s CEO and Chairman, Vlad Vitoc, increased his beneficial ownership in the company to 9.66% through recent open market purchases and equity awards.